Viewing Study NCT05907057

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 6:35 PM

Ignite Modification Date: 2025-12-30 @ 6:08 PM

Study NCT ID: NCT05907057

Status: RECRUITING

Last Update Posted: 2025-04-11

First Post: 2023-06-08

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

Sponsor: Servier Affaires Médicales

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module